Optimization of preparation techniques for poly(lactic acid-co-glycolic acid) nanoparticles

被引:67
作者
Birnbaum, Duane T. [1 ]
Kosmala, Jacqueline D. [1 ]
Brannon-Peppas, Lisa [1 ]
机构
[1] Biogel Technol Inc, Indianapolis, IN 46268 USA
关键词
biodegradable; poly(lactic acid-co-glycolic acid); drug delivery; particle size; aggregation;
D O I
10.1023/A:1010038908767
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Microparticles and nanoparticles of poly(lactic acid-co-glycolic acid) (PLAGA) are excellent candidates for the controlled release of many pharmaceutical compounds because of their biodegradable nature. The preparation of submicron PLAGA particles poses serious challenges that are not necessarily present when preparing microparticles. We have evaluated several combinations of organic solvents and surfactants used in the formulation of PLAGA nanoparticles. Critical factors such as the ability to separate the nanoparticles from the surfactant, the ability to re-suspend the nanoparticles after freeze-drying, formulation yield and nanoparticle size were studied. The smallest particles were obtained using the surfactant/solvent combination of sodium dodecyl sulfate and ethyl acetate (65 nm) and the largest particles were obtained using poly(vinyl alcohol) and dichloromethane (466 nm). However, the optimal nanoparticles were produced using either acetone or ethyl acetate as the organic solvent and poly(vinyl alcohol) or human serum albumin as the surfactant. This is because the most critical measure of performance of these nanoparticles proved to be their ability to re-suspend after freeze-drying.
引用
收藏
页码:173 / 181
页数:9
相关论文
共 27 条
  • [1] IN-VITRO EXTENDED-RELEASE PROPERTIES OF DRUG-LOADED POLY(DL-LACTIC ACID) NANOPARTICLES PRODUCED BY A SALTING-OUT PROCEDURE
    ALLEMANN, E
    LEROUX, JC
    GURNY, R
    DOELKER, E
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (12) : 1732 - 1737
  • [2] ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P13
  • [3] [Anonymous], B I CHEM RES
  • [4] PREPARATION OF BIODEGRADABLE MICROSPHERES AND MICROCAPSULES .2. POLYACTIDES AND RELATED POLYESTERS
    ARSHADY, R
    [J]. JOURNAL OF CONTROLLED RELEASE, 1991, 17 (01) : 1 - 21
  • [5] Ciftci K, 1997, Pharm Dev Technol, V2, P151, DOI 10.3109/10837459709022620
  • [6] Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development
    Cleland, JL
    Johnson, OL
    Putney, S
    Jones, AJS
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) : 71 - 84
  • [7] Gastrointestinal uptake of biodegradable microparticles: Effect of particle size
    Desai, MP
    Labhasetwar, V
    Amidon, GL
    Levy, RJ
    [J]. PHARMACEUTICAL RESEARCH, 1996, 13 (12) : 1838 - 1845
  • [8] In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers
    Dunn, SE
    Coombes, AGA
    Garnett, MC
    Davis, SS
    Davies, MC
    Illum, L
    [J]. JOURNAL OF CONTROLLED RELEASE, 1997, 44 (01) : 65 - 76
  • [9] FALLOUH NA, 1986, INT J PHARM, V28, P125
  • [10] NANOCAPSULE FORMATION BY INTERFACIAL POLYMER DEPOSITION FOLLOWING SOLVENT DISPLACEMENT
    FESSI, H
    PUISIEUX, F
    DEVISSAGUET, JP
    AMMOURY, N
    BENITA, S
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (01) : R1 - R4